Jinzhida Medical Devices (Shanghai) Co., Ltd. is a core medical enterprise under Jinzhida Group. Founded in 2020 in Jiading District, Shanghai, the company is an industry-trade integrated medical device enterprise combining R&D, manufacturing, and sales. Our mission is: to make quality healthcare accessible, safeguard individual health, and enhance the quality of life through technological innovation.
Leveraging the Group's over two decades of profound expertise in composite material R&D and intelligent manufacturing, the company is deeply committed to the field of wound healing promotion. It is equipped with Class 10,000 and Class 100,000 standardized clean production workshops and a professional R&D laboratory. Multiple automated production lines enable large-scale manufacturing of a full range of dressings, with all processes strictly governed by the ISO 13485 medical device quality management system.
Consolidated in 2021 with 9 subsidiaries, headquartered in Jiading, Shanghai. Group revenue reached CNY 1 billion in 2025.
The Group's flagship segment — 5 composite plants nationwide and an industry benchmark. Annual lamination output exceeds 30 million meters, supplying mainstream Chinese automotive brands with a 30% market share. Beyond composite fabrics, the segment independently develops and manufactures China's leading lamination equipment, files multiple patents annually, and is certified as a "High-tech", "Specialized & Innovative", and "Little Giant" enterprise.
The success of the automotive segment laid a solid foundation for the Group's entry into healthcare, accumulating rich lamination-process know-how and technical advantages for the production of medical dressings and related consumables — an end-to-end capability from materials to finished products.
Professional testing services for automotive, medical and other industries, providing strong technical support for the Group's quality control and product R&D — forming a closed loop of "R&D — Manufacturing — Testing".
With our own manufacturing facility at the core and integrated high-quality supply chain resources, we deliver one-stop medical device procurement solutions to global customers.
Focuses on three major product categories — medical dressings, medical care kits, and medical adhesive removers — subdivided into five series: debridement, anti-infection, moisture management, edge management, and auxiliary products, comprehensively addressing clinical needs across superficial wound care, post-operative protection, trauma repair, and medical adhesive removal.
Covers seven series: home healthcare, rehabilitation, basic low-value consumables, portable diagnostic devices, maternal and infant products, emergency / operating room supplies, and dental products — building a one-stop medical device procurement matrix.
From Group heritage to global network — building one-stop comprehensive wound management solutions.
Backed by Jinzhida Group's 20+ years of composite material R&D and intelligent manufacturing expertise — a profound technological foundation.
R&D, manufacturing and sales in one, with our own plant plus a curated supply chain — 3 core categories and 7 extended series fully covered.
Deeply rooted in wound healing promotion, with 5 dressing series fully adapted to deliver one-stop comprehensive wound management.
Class 10,000 and 100,000 cleanrooms, full ISO 13485 governance, with core products certified by EU CE and US FDA.
Mature OEM / ODM capabilities supporting full customization of specifications, formulations, packaging and appearance.
Dual coverage of domestic healthcare institutions and overseas markets, digital export via Alibaba.com, and an expanding global distribution network.
Core dressing business + full-category medical device extension — a one-stop procurement solution for global customers.
Since launching its internationalization strategy in 2025, the company has established an official store on Alibaba.com, building a comprehensive product showcase and online inquiry system. Factory capabilities, certification credentials, and customization expertise are presented in one place, making it a core digital platform for precise overseas customer acquisition and brand expansion. Multiple core products have obtained EU CE and US FDA certifications, with overseas shipments becoming a regular occurrence. The company is now deeply engaged in overseas OEM/ODM cooperation, with mature customization capabilities covering product specifications, formulations, packaging, and appearance tailored to customer requirements.
